Press release
Primary Hyperoxaluria Treatment Market Outlook by Examining the Results of Different Competitors Through 2031 - Alnylam Pharmaceuticals, Novo Nordisk A/S., Zhejiang Tianxin Pharmaceutical Co., Ltd.
Primary Hyperoxaluria Treatment Market
Download a Free sample PDF (Use Corporate email ID to Get Higher Priority) at: - https://datamintelligence.com/download-sample/primary-hyperoxaluria-treatment-market
What is the projected growth rate (CAGR) of the Global Primary Hyperoxaluria Treatment market from 2024 to 2031, and what is the market value expected to change by 2031?
The global primary hyperoxaluria treatment market reached US$ 168.96 million in 2023 and is expected to reach US$ 365.49 million by 2031, growing at a CAGR of 9.8% during the forecast period 2024-2031.
Primary hyperoxaluria treatment focuses on reducing the overproduction of oxalate, which can lead to kidney stones and renal failure. Standard approaches include increased hydration, dietary modifications, and medications such as pyridoxine. Advanced therapies, including RNA interference and gene editing, aim to target the genetic causes of the disorder. Dialysis and kidney transplantation may be necessary in severe cases. Early diagnosis improves long-term prognosis and quality of life.
Key Developments:
❁ Alnylam Pharmaceuticals launched OXLUMO (Lumasiran), the first approved medication for PH in the U.S., but the company generates most of its revenue from European countries. In 2023, Alnylam reported total sales of US$ 109.8 million, with US$ 60 million coming from Europe. This marks a significant shift from 2022, when the company generated US$ 37 million from Europe, reflecting a 58% increase in sales in the region.
List of the Key Players in the Primary Hyperoxaluria Treatment Market:
Alnylam Pharmaceuticals, Novo Nordisk A/S., Zhejiang Tianxin Pharmaceutical Co., Ltd., DSM, BASF, Fagron, Pfizer Inc., AdvaCare Pharma, Sanofi and Viatris Inc.
Research Process:
Both primary and secondary data sources have been used in the global Primary Hyperoxaluria Treatment Market research report. During the research process, a wide range of industry-affecting factors are examined, including governmental regulations, market conditions, competitive levels, historical data, market situation, technological advancements, upcoming developments, in related businesses, as well as market volatility, prospects, potential barriers, and challenges.
Segment Covered in the Primary Hyperoxaluria Treatment Market:
By Type: Primary Hyperoxaluria Type I, Primary Hyperoxaluria Type II, Primary Hyperoxaluria Type III.
By Treatment Type: Medication, Dialysis, Transplantation.
Regional Breakout:
The global Primary Hyperoxaluria Treatment Market report focuses on six major regions: North America, Latin America, Europe, Asia Pacific, the Middle East, and Africa.
✫ North America (U.S., Canada, Mexico)
✫ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)
✫ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)
✫ South America (Colombia, Brazil, Argentina, Rest of South America)
✫ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)
Get Year End Discounts on Premium Report:- https://www.datamintelligence.com/buy-now-page?report=primary-hyperoxaluria-treatment-market
This Report Unveils:
✔ Go to Market Strategy- A roadmap to successfully product launch or service in the target market.
✔ Gain a clear picture of the market's health and growth trajectory through neutral analysis.
✔ Deep Market Insights delve into development trends, competitor landscape, supply and demand dynamics, brand share & pricing analysis year-over-year growth patterns, and key players' performance.
✔ Upon request, we can provide customized reports focusing on specific regions or countries, offering a granular view of their markets.
✔ Identify high-potential niche segments and regions poised for significant expansion.
✔ Analysis of Market Size (historical and forecast) Total Addressable Market (TAM), Serviceable Available Market (SAM), and Serviceable Obtainable Market (SOM) to understand the market's overall size and your achievable market share.
✔ Gain a comprehensive understanding of the competitive landscape, including market share distribution, key players (innovators, startups, laggards, and pioneers), and their respective strengths and weaknesses.
**The full version of the report includes an in-depth analysis of emerging players and startups, which will provide valuable insights into the evolving market landscape and key strategies being adopted**
Chapter Outline:
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: key insights, key emerging trends, etc.
Chapter 3: Manufacturers competitive analysis, detailed analysis of Primary Hyperoxaluria Treatment manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 5 & 6: Revenue of Primary Hyperoxaluria Treatment in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 7: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the Primary Hyperoxaluria Treatment market in different market segments.
Chapter 8: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the Primary Hyperoxaluria Treatment market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: The main points and conclusions of the report.
Get Customization in the report as per your requirements:- https://datamintelligence.com/customize/primary-hyperoxaluria-treatment-market
Frequently Asked Questions
☞ What is the expected growth rate of the global Primary Hyperoxaluria Treatment market for the forecast period?
☞ What are the key driving factors that are responsible to shape the fate of the Primary Hyperoxaluria Treatment market during the forecast period?
☞ What will be the overall size of the market during the analysis period?
☞ What are the prominent market trends which influence the development of the Primary Hyperoxaluria Treatment market across various regions?
☞ Who are the key market players and the market strategies that have helped them to secure the leading position in the global market?
☞ What are the challenges and threats that are likely to act as a barrier to the growth of the Primary Hyperoxaluria Treatment market?
☞ What are the major opportunities that the companies can get to attain success in the world?
Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com
About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Primary Hyperoxaluria Treatment Market Outlook by Examining the Results of Different Competitors Through 2031 - Alnylam Pharmaceuticals, Novo Nordisk A/S., Zhejiang Tianxin Pharmaceutical Co., Ltd. here
News-ID: 3738590 • Views: …
More Releases from DataM Intelligence 4market Research LLP
Agricultural Testing Market Set to Grow at 5.98% CAGR Through 2031 | Japan Inves …
DataM Intelligence has published a new research report on "Agricultural Testing Market Size 2025". The report explores comprehensive and insightful Information about various key factors like Regional Growth, Segmentation, CAGR, Business Revenue Status of Top Key Players and Drivers. The purpose of this report is to provide a telescopic view of the current market size by value and volume, opportunities, and development status.
Global Agricultural Testing Market is expected to grow…
United States Adjuvants Market 2025-2031: Opportunities Across Vaccines, Insecti …
DataM Intelligence has published a new research report on "Adjuvants Market Size 2025". The report explores comprehensive and insightful Information about various key factors like Regional Growth, Segmentation, CAGR, Business Revenue Status of Top Key Players and Drivers. The purpose of this report is to provide a telescopic view of the current market size by value and volume, opportunities, and development status.
The Global Adjuvants Market is expected to grow at…
United States Fatty Acid Supplement Market Set to Surge by 2032 Driven by Omega- …
DataM Intelligence has published a new research report on "Fatty Acid Supplement Market Size 2025". The report explores comprehensive and insightful Information about various key factors like Regional Growth, Segmentation, CAGR, Business Revenue Status of Top Key Players and Drivers. The purpose of this report is to provide a telescopic view of the current market size by value and volume, opportunities, and development status.
Get a Sample PDF Of This Report…
United States E-Fuel Market Set to Skyrocket to US$215B by 2032 at 48.96% CAGR | …
Global E-fuel market size reached US$ 8.89 billion in 2024 and is expected to reach US$ 215.51 billion by 2032, growing with a CAGR of 48.96% during the forecast period 2025-2032.
The e-fuel market encompasses synthetic fuels produced by combining renewable electricity with carbon dioxide and water. These fuels, including e-methanol, e-diesel, and e-gasoline, serve as sustainable alternatives to fossil fuels in sectors like transportation and aviation. E-fuels can be…
More Releases for Primary
Direct Primary Care Market
Direct Primary Care Market Worth 80.4 Bn 2031- Exclusive Report by InsightAce Analytic Pvt. Ltd.
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Direct Primary Care Market"- By Type (Clinical Services, Telehealth Services, Laboratory Services, Consultative Services), Care Setting (Office-Based DPC Practices, Home-Based DPC Practices, Telehealth-Only DPC Practices, Hybrid DPC Practices), End Users (Individuals, Employers, Small Businesses, Large Corporations, Insurance Companies (offering DPC as…
Primary Sclerosing Cholangitis Market
Primary Sclerosing Cholangitis (PSC) is a rare, chronic liver disease characterized by inflammation and scarring of the bile ducts, leading to liver damage and, ultimately, liver failure. The disease progresses slowly and often goes unnoticed in its early stages. Although the exact cause of PSC remains unknown, it is commonly associated with other inflammatory bowel diseases, particularly ulcerative colitis. The management of PSC includes symptom control, slowing disease progression, and…
Primary Biliary Cholangitis Treatment Market
Primary Biliary Cholangitis Treatment Market
Global Primary Biliary Cholangitis Treatment Market Expected to Reach US$ YY Million by 2030, Growing at a CAGR of YY%: Market Insights and Dynamics
The Global Primary Biliary Cholangitis Treatment Market, which reached US$ YY billion in 2022, is anticipated to achieve US$ YY million by 2030, exhibiting a robust CAGR of YY% during the forecast period from 2024 to 2031.
Primary Biliary Cholangitis (PBC), formerly known as…
Primary Healthcare Conference 2023
3rd World Congress on Primary Healthcare and Medicare Summit
Mercure Roma West, Viale degli Eroi di Cefalonia, 301, 00128 Rome, Italy
Email primaryhealthcare@pulsusgathering.org
On behalf of the Conference Organizing Committee, we would like to invite all of you for the "3rd Word Congress on Primary Healthcare and Medicare", which is going to be held in Rome, Italy on September 21-23, 2023. Primary Healthcare 2023 focuses on the basic theme "To Manifest the Multimorbidity…
Primary Lithium Battery (Primary Lithium Batteries) Market Key Companies and Ana …
The global lithium primary batteries market size will grow from $2.83 billion in 2022 to $2.9 billion in 2023 at a compound annual growth rate (CAGR) of 2.5%
Global " Primary Lithium Battery (Primary Lithium Batteries) Market" 2022 Reports give a Key study on the industry status of the Primary Lithium Battery (Primary Lithium Batteries) Manufacturer with the specific statistics, meaning, definition, SWOT Analysis, expert opinion, and recent development across…
Primary Prevention of Cancer
Primary prevention of cancer aims to prevent the disease before it ever occurs. More than 4 in 10 cancers as well as cancer deaths are linked to modifiable risk factors that can be altered as part of primary cancer prevention. The modifiable risk factors for primary prevention include:
1. Cigarette smoking: Smoking causes almost all cases of lung cancer and accounts for 30% of all cancer deaths. Prevention strategy for this risk…
